As employers increasingly drop insurance coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound, major retailers such as Walmart, Costco, CVS, and Amazon are expanding direct-to-consumer prescription programs to capture market share. These programs offer low-cost monthly prescriptions, encouraging long-term customer relationships that extend beyond just the medication to other store purchases. While this shift benefits large retail chains by driving recurring foot traffic and sales, independent pharmacies face volume losses and challenges in managing patient care due to fragmented prescription sources. The trend highlights a strategic pivot in retail healthcare, with big chains betting on obesity treatment as a gateway to broader consumer engagement despite concerns about patient care continuity and profitability challenges in healthcare services.
DoorDash has received FAA Part 135 air carrier certification, allowing it to launch its own drone delivery service. This milestone enables faster delivery of essentials and time-sensitive items, improving local commerce by routing mid-range deliverie...
Walmart Canada, its associates, and customers raised $7.2 million this spring to support children's hospital foundations across Canada. The funds will be used for vital equipment, research, training, and programs to improve pediatric care locally. Th...
Walmart Canada, its employees, and customers raised $7.2 million this spring to support children's hospital foundations across Canada. The funds will help provide life-changing equipment, advance research, support specialized training, and improve pr...
Investors are rotating out of AI infrastructure stocks such as Micron and Western Digital, which surged earlier this year due to memory shortages but have recently declined. CNBC's Jim Cramer highlights a shift toward companies with broader growth dr...
